The Discounted Cash Flow (DCF) valuation of Bioventus Inc (BVS) is (13.73) USD. With the latest stock price at 11.14 USD, the upside of Bioventus Inc based on DCF is -223.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.9% - 14.4% | 11.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (26.69) - (10.48) | (13.73) |
| Upside | -339.6% - -194.1% | -223.3% |